These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15755657)

  • 21. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4005-11. PubMed ID: 15225716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of cyclooxygenase inhibitors on the bone and cartilage].
    Burdan F
    Pol Merkur Lekarski; 2005 Jun; 18(108):709-11. PubMed ID: 16124389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses.
    Marsik P; Kokoska L; Landa P; Nepovim A; Soudek P; Vanek T
    Planta Med; 2005 Aug; 71(8):739-42. PubMed ID: 16142638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COX-2 inhibitory activity of homoisoflavanones and xanthones from the bulbs of the Southern African Ledebouria socialis and Ledebouria ovatifolia (Hyacinthaceae: Hyacinthoideae).
    Waller CP; Thumser AE; Langat MK; Crouch NR; Mulholland DA
    Phytochemistry; 2013 Nov; 95():284-90. PubMed ID: 23859260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR analysis of 1,3-diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives as selective COX-2 inhibitors.
    Silakari P; Shrivastava SD; Silakari G; Kohli DV; Rambabu G; Srivastava S; Shrivastava SK; Silakari O
    Eur J Med Chem; 2008 Jul; 43(7):1559-69. PubMed ID: 18023931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses.
    Jain HK; Mourya VK; Agrawal RK
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5280-4. PubMed ID: 16908140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cadmium accumulation on anti-inflammatory activity in two Eucomis species.
    Street RA; Elgorashi EE; Kulkarni MG; Stirk WA; Southway C; Van Staden J
    Bull Environ Contam Toxicol; 2009 Nov; 83(5):644-7. PubMed ID: 19768359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2097-102. PubMed ID: 15808476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors.
    Huntjens DR; Danhof M; Della Pasqua OE
    Rheumatology (Oxford); 2005 Jul; 44(7):846-59. PubMed ID: 15855183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
    Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents.
    Ottanà R; Maccari R; Barreca ML; Bruno G; Rotondo A; Rossi A; Chiricosta G; Di Paola R; Sautebin L; Cuzzocrea S; Vigorita MG
    Bioorg Med Chem; 2005 Jul; 13(13):4243-52. PubMed ID: 15905093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring QSAR with E-state index: selectivity requirements for COX-2 versus COX-1 binding of terphenyl methyl sulfones and sulfonamides.
    Chakraborty S; Sengupta C; Roy K
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4665-70. PubMed ID: 15324885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
    Gupta MK; Prabhakar YS
    Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
    Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
    Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parallel synthesis and in vitro activity of novel anthranilic hydroxamate-based inhibitors of the prostaglandin H2 synthase peroxidase activity.
    Lee J; Chubb AJ; Moman E; McLoughlin BM; Sharkey CT; Kelly JG; Nolan KB; Devocelle M; Fitzgerald DJ
    Org Biomol Chem; 2005 Oct; 3(20):3678-85. PubMed ID: 16211102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.